Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NITROFURAZONE vs NIVOLUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NITROFURAZONE vs NIVOLUMAB: Safety Overview

Metric NITROFURAZONE NIVOLUMAB
Total FAERS Reports 307 87,742
Deaths Reported 298 23,086
Death Rate 97.1% 26.3%
Hospitalizations 87 36,530
Average Patient Age 44.0 yrs 64.2 yrs
% Female Patients 99.4% 34.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer N/A E.R. Squibb & Sons, L.L.C.
Route N/A INTRAVENOUS
Marketing Status Discontinued Prescription